Clinical TrialsSearch results
Number of results: 1266
Other
- A late phase II study of multidisciplinary approach to establish standard treatment for advanced neuroblastoma
- neuroblastoma
- Japan Neuroblastoma Study Group
- 2008-02-20
Other
- A Late Phase II Study of PET Testing Using NMB58 to Assess Myocardial Blood Flow in Patients With Suspected Ischemic Heart Disease.
- ischemic heart disease
- Takai Kenichiro
- 2023-03-02
Other
- A long-term study of beta-glucuronidase enzyme replacement therapy for Sly disease
- Mucopolysaccharidosis type VII
- Hamazaki Takashi
- 2019-12-19
Other
- A long-term study of NPC-12G gel in neurofibromatosis type I
- Neurofibromatosis type 1
- Kaneda Mari
- 2020-07-06
Other
- A multi institutional phase II trial of peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen.
- Adult T cell leukemia/lymphoma
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan
- 2006-05-01
Other
- A multi-center comparative study of three coma scales: Japan Coma Scale, Glasgow Coma Scale and Emergency Coma Scale : E-COMET STEP I
- consciousness disturbance
- Japan ECS Society
- 2007-04-05
Other
- A multi-center randomized phase II study of nutritonal support with intensive glucose control after allogeneic stem cell transplantation lipid-free vs lipid
- hematological malignancies
- National Cancer Center Hospital
- 2008-06-16
Completed
- A MULTI-CENTER, OPEN-LABEL, PHASE 2 STUDY TO EVALUATE SAFETY AND EFFICACY OF U3- 1402 IN SUBJECTS WITH ADVANCED OR METASTATIC COLORECTAL CANCER (CRC)
- Metastatic Colorectal Cancer
- Inoguchi Akihiro
- 2020-10-08
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10